The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The role of phase I clinical trials in advanced malignant melanoma: Retrospective analysis of CTEP-sponsored trials 1995-2011.
Jason John Luke
No relevant relationships to disclose
Larry Rubinstein
No relevant relationships to disclose
Gary L Smith
No relevant relationships to disclose
S. Percy Ivy
No relevant relationships to disclose
Pamela Jo Harris
No relevant relationships to disclose